JAK inhibitors for the treatment of autoimmune and inflammatory diseases
Top Cited Papers
- 11 September 2019
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 18 (11), 102390
- https://doi.org/10.1016/j.autrev.2019.102390
Abstract
No abstract availableKeywords
This publication has 189 references indexed in Scilit:
- Janus kinase inhibitors in autoimmune diseasesAnnals Of The Rheumatic Diseases, 2013
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative ColitisThe New England Journal of Medicine, 2012
- A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the SkinJournal of Investigative Dermatology, 2012
- Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility lociNature Genetics, 2010
- The Expression of STAT-1 and Phosphorylated STAT-1 in Conjunctival GranulomasOcular Immunology and Inflammation, 2010
- Th17 and Th1 T-Cell Responses in Giant Cell ArteritisCirculation, 2010
- Hypothesis: Sarcoidosis is a STAT1-mediated diseaseClinical Immunology, 2009
- New insights into the roles of Stat5a/b and Stat3 in T cell development and differentiationSeminars in Cell & Developmental Biology, 2008
- Cytokines and their role in lymphoid development, differentiation and homeostasisCurrent Opinion in Allergy and Clinical Immunology, 2002
- Cytokines and autoimmunityNature Reviews Immunology, 2002